AMGN Amgen
- Official Name: AMGEN INC.
- Headquarters: One Amgen Center Drive, THOUSAND OAKS, CA, 91320-1799 US
- CEO: Robert A. Bradway
- Website: amgen.com
- Key Investor: VANGUARD GROUP INC | 9.83%
- Dedicated Investor: ROUND HILL ASSET MANAGEMENT | 9.69%
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-17 | 1 | Lost by 2.145 | (1.528) - 0.617 | ||
| 2025-07-24 | 2 | Lost by 3.682 | 2.899 - 6.581 | ||
| 2025-07-29 | 2R | Won by 3.450 | 2.349 - (1.101) | ||
| 2025-07-31 | 3 | Lost by 12.306 | (7.955) - 4.351 | ||
| 2025-08-07 | 4 | Lost by 3.570 | (3.118) - 0.452 | ||
| 2025-08-07 | 1R | Lost by 1.554 | 0.504 - 2.058 | ||
| 2025-08-12 | 3R | Lost by 0.964 | (0.158) - 0.806 | ||
| 2025-08-14 | 5 | Won by 0.385 | 1.814 - 1.429 | ||
| 2025-08-21 | 6 | Won by 3.889 | 1.996 - (1.893) | ||
| 2025-08-28 | 7 | Lost by 1.822 | (3.537) - (1.715) | ||
| 2025-09-03 | 1R | Lost by 1.312 | (1.069) - 0.243 | ||
| 2025-09-04 | 8 | Lost by 6.693 | (1.876) - 4.817 | ||
| 2025-09-11 | 9 | Won by 2.498 | 0.937 - (1.561) | ||
| 2025-09-18 | 10 | Lost by 3.539 | (2.540) - 0.999 | ||
| 2025-09-25 | 11 | Won by 0.709 | (1.338) - (2.047) | ||
| 2025-10-02 | 12 | Won by 10.367 TOTW | 8.608 - (1.759) | ||
| 2025-10-09 | 13 | Lost by 0.546 | (0.643) - (0.097) | ||
| 2025-10-16 | 14 | Won by 2.891 | 0.130 - (2.761) | ||
| 2025-10-23 | 15 | Lost by 3.524 | (1.021) - 2.503 |
Latest News
2 Healthcare Stocks That Just Delivered Great News for Investors
And there could be more positive developments ahead.
Amgen’s Deerfield office campus sold to Mesirow for $151M in sale-leaseback deal
Mesirow CEO Richard S. Price with 1 Horizon Way in Deerfield (Getty, Mesirow, Google Maps)An entity tied to Chicago financial services firm Mesirow bo...
Amgen (AMGN) Rises Higher Than Market: Key Facts
In the latest trading session, Amgen (AMGN) closed at $414.61, marking a +2.11% move from the previous day.
Exploring the top movers within the dow jones index during today's session.
Curious about the dow jones stocks that are in motion on Friday? Join us as we explore the top movers within the dow jones index during today's s...
Is LLY Stock Cheaper Than It Looks?
At about $1,182 a share, Eli Lilly (LLY) stock trades at about 33.1 times trailing earnings. Those are adjusted earnings: normalized net income with s...
Friday's session: top gainers and losers in the dow jones index
Curious about the dow jones stocks that are in motion on Friday? Join us as we explore the top movers within the dow jones index during today's s...
How To Build A $75,000 Dividend Portfolio With SCHD And 5 High-Yield Picks
Build a $75K dividend portfolio anchored by SCHD, enhanced with JEPI, VNG, and 8 quality stocks to boost yield, growth, and diversificationâread ...
Keystone To Launch India Business With Bengaluru As First Hub, Plans To Hire Talent & Increase Workforce Over Next Two Years
Keystone, a global advisory firm that guides the most critical technology and science-based platforms and ecosystems, today announced it is establishi...
10 Health Care Stocks With Whale Alerts In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transac...
Bet on These 5 Dividend Growth Stocks Amid Rising Treasury Yields
Rising Treasury yields are reshaping market preferences, putting dividend growth stocks like EnerSys and Amgen in focus for income and growth.
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to Amgen (AMGN). This makes it worthwhile to examine what the stock has in store.
How Investors Are Reacting To Veeva Systems (VEEV) Expanding Agentic AI And Winning New Pharma Clients
In recent days, Veeva Systems has rolled out new AI-powered tools such as Veeva Study Builder Agent and Veeva Falcon Router, while announcing major cu...
Winners And Losers Of Q2: Amgen (NASDAQ:AMGN) Vs The Rest Of The Therapeutics Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are ...
Stay informed with the top movers within the dow jones index on Thursday.
Curious about the top performers within the dow jones index one hour before the close of the markets on Thursday? Dive into the list of today's s...
Can Eli Lilly Stock Catch Up To Rivals It Outgrows?
Eli Lilly (LLY) grew revenue 49.6% over the last twelve months, the fastest of the six companies in its peer group. It also runs the group's wide...
How a Roth IRA Can Keep Thousands More of Your DJIA Dividend Income Compounding
Holding blue-chip Dow dividend payers in a taxable account quietly hands the IRS a cut of every reinvested dollar, year after year, and the compoundin...
Novo Nordisk: Capital Markets Day Reveals Its Next Growth Engine
Novo Nordisk A/Sâs 2030 pipeline targets, Wegovy pill growth and Q2 sales show major upside. Click for this NVO stock update.
UPLIZNA Market Poised for Growth Through 2034 as Expanding Indications and Rising Demand Drive Sales Opportunities
UPLIZNA growth is driven by new indications, global expansion, strong efficacy, differentiated CD19 targeting and twice-yearly dosing, though competit...
Amgen (AMGN) Is Up 7.9% After Positive Phase 3 Dazodalibep Data in Systemic Sjögren’s Disease
Amgen recently reported positive topline Phase 3 OASIZ 301 results for dazodalibep in adults with moderate-to-severe systemic Sjögren’s disease, sh...
Amgen price target raised by Jefferies to $410 after positive Sjögren's data
Amgen Inc (NASDAQ:AMGN, XETRA:AMG)'s price target was raised to $410 from $367 by Jefferies after dazodalibep delivered positive Phase 3 results ...
Viking's Obesity Edge May Be Staying Power, Not Weight Loss
Viking Therapeutics shares jumped 36% after VK2735 maintenance data showed patients kept most weight loss on less frequent dosing, though Phase 3 resu...
Stay informed with the top movers within the dow jones index on Wednesday.
Stay updated with the movement of dow jones stocks in today's session. Discover which dow jones stocks are making waves on Wednesday.
AMGN's Dazodalibep Meets Goal in Systemic Sjogren's Disease Study
Amgen's dazodalibep meets its primary goal in a Phase III study, showing sustained improvement in systemic Sjogren's disease activity throug...
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transac...
Novo Nordisk Stock Slides After Unveiling Long Term Pipeline Growth Targets
Key Stats for Novo Nordisk StockPrice change for Novo Nordisk stock in last 1 year: -35%$NVO Stock Price as of Sep. 22: $3952-Week High: $64$NVO Stock...
Amgen Stock Gains After Announcing Positive Phase 3 Sjögren’s Disease Trial Results
Key Stats for Amgen StockPrice change for Amgen stock in last 1 year: 43%$AMGN Stock Price as of Sep. 22: $41052-Week High: $447$AMGN Stock Price Targ...
Vault CRM Extends Market Leadershipas Another Top 20 Biopharma Chooses Veeva
Veeva Systems (NYSE: VEEV) today announced a new top 20 biopharma commitment, adding to recent selections by Amgen, Biogen, Eli Lilly and Company, and...
Sector Update: Healthcare Stocks Rise Late Afternoon
Healthcare stocks rose late Tuesday afternoon, with the NYSE Healthcare Index adding 0.5% and the St
Tuesday's session: top gainers and losers in the dow jones index
Uncover the latest developments among dow jones stocks in today's session. Stay tuned to the dow jones index's top gainers and losers on Tue...
Discover which S&P500 stocks are making waves on Tuesday.
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Tuesday as we examine the late...
Amgen reports a Phase 3 win with Sjögren’s drug candidate
Dazodalibep, acquired in Amgen’s big buyout of Horizon Therapeutics, succeeded in the first of two late-stage trials against the tough-to-treat auto...
AMGN Jumps After Win In Sjögren’s Disease Trial As Citi Flags ‘Open Questions’
In a trial in patients with Sjögren’s disease, Amgen’s dazodalibep produced a statistically significant and clinically meaningful improvement on ...
Stock Market Today: Dow Skids As Trump Threatens Iran; Medical Diagnostics Plays Swoon (Live Coverage)
Stock Market Today: The Dow Jones index was lower after President Trump threatened Iran at the UN. Apple stock is near a buy point.
Amgen (AMGN) Posted Positive Phase 3 Results In Sjögren's Disease
Amgen (NasdaqGS:AMGN) reported positive Phase 3 trial results for dazodalibep in Sjögren's disease, targeting a major unmet autoimmune need. The...
Uncover the latest developments among dow jones stocks in today's session.
Let's have a look at the top dow jones gainers and losers in the middle of the day of today's session.
These S&P500 stocks are moving in today's session
Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.
Stock Market Today: Dow Slips But Apple Touches A Buy Point; Homebuilder, Retailer Funds Shine (Live Coverage)
Stock Market Today: The Dow Jones index reversed lower despite new U.S.-Iran peace hopes. Apple stock is trading near a buy point.
Amgen Boasts Success In Sjogren's; Shares Charge Ahead
Amgen stock bounded above its 50-day line Tuesday after publishing promising results for its experimental Sjogren's treatment.
Amgen Hits Primary Endpoint In Sjögren's Trial, But Approval Filing Awaits Another Trial Data
Amgen's Phase 3 study shows dazodalibep significantly improves systemic disease activity in adults with Sjögren's disease.
AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR DAZODALIBEP IN MODERATE-TO-SEVERE SYSTEMIC SJÖGREN'S DISEASE
Amgen (NASDAQ:AMGN) today announced positive topline results from the Phase 3 OASIZ 301 study evaluating dazodalibep in adults with Sjögren's di...